No corporate weight control program has ever reported savings or even sustained weight loss using valid metrics across a sizable population for 2 years or more, accounting for dropouts and ...

MALAGA, Spain—Patients with obesity treated with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide (Wegovy; Novo Nordisk) can achieve weight loss in the real world similar to what has ...

SAN DIEGO — Weight-reduction programs help patients maintain a weight loss of 8% to 10% for longer than a year, researchers reported during a symposium on exercise in medicine here at the American ...

San Gabriel Practice Details Physician-Supervised Weight Management Options San Gabriel, United States - February 18, ...

Individuals seeking weight loss medications, including glucagon-like peptide 1 (GLP-1) agonists like Zepbound or Mounjaro, can now skip the doctor’s office and get prescriptions via virtual GLP-1 ...

A recent study was conducted by Pakhale and colleagues to determine whether weight reduction by dieting could ameliorate airway hyperresponsiveness (AHR), a characteristic and quantifiable feature of ...

Credit: Getty Images By reinforcing the essential role of exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and improves functional health.